Clinical trials
Recruiting Squamous Cell Carcinoma of Head and Neck trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
372 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 13 |
| 2021 | 30 |
| 2022 | 23 |
| 2023 | 58 |
| 2024 | 78 |
| 2025 | 79 |
| 2026 | 74 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 372 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 11 |
| National Cancer Institute (NCI) | 8 |
| Vanderbilt-Ingram Cancer Center | 7 |
| West China Hospital | 7 |
| Memorial Sloan Kettering Cancer Center | 6 |
| AbbVie | 5 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 5 |
| University Health Network, Toronto | 5 |
| University of Erlangen-Nürnberg Medical School | 5 |
| Beijing Tongren Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 372 |
| Head and Neck Neoplasms | 67 |
| Carcinoma, Non-Small-Cell Lung | 62 |
| Mouth Neoplasms | 41 |
| Melanoma | 34 |
| Triple Negative Breast Neoplasms | 33 |
| Carcinoma, Squamous Cell | 32 |
| Neoplasm Metastasis | 29 |
| Uterine Cervical Neoplasms | 28 |
| Colorectal Neoplasms | 27 |
Trials
Showing 26 to 50 of 372. Each trial links to its page on Pharma Observatory.
272 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.